Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Boswellia sacra oleoresin extract, commonly known as frankincense extract, is a natural product derived from the oleoresin of *Boswellia sacra* trees. Researchers at Tanta University investigated this extract, prepared via cold maceration with ethanol, for its potential therapeutic application in periodontitis. The extract contains a complex mixture of volatile compounds, including trans-nerolidyl formate, cycloartenol acetate, and ursenoic acid 3-oxomethyl ester. It demonstrates significant antibacterial and antibiofilm activity against *Porphyromonas gingivalis*, a primary pathogen in chronic periodontitis. Its mechanism of action involves disrupting bacterial membrane integrity and downregulating the expression of key virulence genes, specifically *fimA* (fimbriae protein A), *hagA* (hemagglutinin A), and *hagB* (hemagglutinin B).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Boswellia sacra oleoresin extract.